Invention Grant
- Patent Title: Compounds and methods for modulating FX-receptors
- Patent Title (中): 用于调节FX-受体的化合物和方法
-
Application No.: US12159224Application Date: 2007-02-02
-
Publication No.: US07863302B2Publication Date: 2011-01-04
- Inventor: Michael Gregory Bell , Michael James Genin , Peter Ambrose Lander , Lindsay Scott Stelzer , Robert Anthony Doti , Francisco Javier Agejas-Chicharro , Ana Belen Bueno Melendo , Peter Rudolph Manninen , Jason Matthew Ochoada , Quanrong Shen , Alan M. Warshawsky , Tianwei Ma , Ryan Edward Stites
- Applicant: Michael Gregory Bell , Michael James Genin , Peter Ambrose Lander , Lindsay Scott Stelzer , Robert Anthony Doti , Francisco Javier Agejas-Chicharro , Ana Belen Bueno Melendo , Peter Rudolph Manninen , Jason Matthew Ochoada , Quanrong Shen , Alan M. Warshawsky , Tianwei Ma , Ryan Edward Stites
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Francis O. Ginah
- International Application: PCT/US2007/061515 WO 20070202
- International Announcement: WO2007/092751 WO 20070816
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61K31/422 ; A61K31/428 ; A61P3/10 ; C07D261/06 ; C07D275/04 ; C07D277/20
Abstract:
Compounds of formula and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
Public/Granted literature
- US20080306125A1 Compounds and Methods for Modulating Fx-Receptors Public/Granted day:2008-12-11
Information query
